Selective amino acid substitutions of a subdominant Epstein‐Barr virus LMP2‐derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein‐Barr virus‐associated malignancies
暂无分享,去创建一个
A. Canella | R. Gavioli | R. Guerrini | F. Micheletti | M. Marastoni | R. Tomatis | S. Traniello | M. Bazzaro | Annarita Formentin